Journal of Drugs in Dermatology

View more issues:

Articles in Jan, 2007 issue of Journal of Drugs in Dermatology

• Comparison of adverse events of laser and light-assisted hair removal systems in skin types IV-VI
  by Jonith Y. Breadon
• Humira received expanded FDA approval in treatment of psoriatic arthritis
  by Marissa Heller
• Ceftobiprole in the treatment of resistant Staphylococcus aureus skin and skin structure infections
• Gefitinib in treating patients who are undergoing surgery and/or radiation therapy for locally advanced or recurrent squamous cell skin cancer
• Cultural and ethnic differences in the acceptance or rejection of liposuction instrumentation entrance marks
  by Lawrence M. Field
• FDA approves Mylan's doxycycline tablets
  by Marissa Heller
• Celecoxib in preventing skin cancer
• Common allergens in skin tests for adult atopic dermatitis
• Dermatosis papulosis nigra: treatment options
  by Mary P. Lupo
• Treatment options for the papulopustular eruption of gefitinib
  by Frank C. Victor
• FDA approves Zolinza for treatment of cutaneous T cell lymphoma
  by Marissa Heller
• T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant
• Study of recombinant human Thrombin for bleeding during autologous skin grafting
• Soft tissue augmentation in skin of color: market growth, available fillers, and successful techniques
  by Cheryl M. Burgess
• Adalimumab in the treatment of moderate to severe psoriasis
  by Marissa Heller
• Study comparing the safety and efficacy of tigecycline with ampicillin-sulbactam or amoxicillin-clavulanate to treat skin infections
• The acquisition of blood and skin samples from normal volunteers to support research activities on dermatologic diseases
• Sunscreen use and usefulness in African-Americans
  by James J. Briley, Jr.
• Cutaneous side effects of cetuximab and erlotinib
  by Frank C. Victor
• Additional positive results for telavancin
  by Marissa Heller
• Comparing skin disinfectants before labor epidural analgesia
• Determining the photoadaptation of depigmented skin to targeted phototherapy using UVB in patients with vitiligo
• Insight into skin lightening cosmeceuticals for women of color
  by Sonia Badreshia-Bansal
• FDA approves generic Sulfacetamide
  by Marissa Heller
• A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and Enterococcus
  by Noah Scheinfeld
• Atopic dermatitis-like skin disease in pediatric heart transplant patients
• Hair removal with the 3-msec alexandrite laser in patients with skin types IV-VI: efficacy, safety, and the role of topical corticosteroids in preventing side effects
  by Mohammed S. Aldraibi
• ArteFill approved by the FDA
  by Marissa Heller
• Reconstitution with pimecrolimus cream 1% of steroid-damaged skin in adults with atopic dermatitis
• The effects of microdermabrasion on skin remodeling
• Letter from the guest editor
  by Ella L. Toombs
• Laser and light-based treatment of cellulite
  by Macrene Alexiades-Armenakas
• FDA approves Noxafil for oropharyngeal candidiasis
  by Marissa Heller
• Topical morphine for analgesia in patients with skin grafts
• Hematopoietic stem cell support in patients with autoimmune bullous skin disorders
• Surgical therapy of acne scars in pigmented skin
  by James M. Swinehart
• Topical tacrolimus for the treatment of lichen sclerosus
  by Marissa Heller
• The effect of Efudex treatment on photoaged skin
• T cell repertoire analysis of immune mediated skin diseases
• Erratum
• Selected dermatoses in children of color
  by Roselyn E. Epps
• Transacin for post-herpetic neuralgia
  by Marissa Heller
• Effect of bosentan on skin fibrosis in patients with systemic sclerosis
• Sunless tanning products as a substitute for sunbathing in healthy participants